Assessment of adiponectin and its isoforms in Polish centenarians

Experimental Gerontology

Volumn 48, Issue 4, 2013, Pages 401-407

  Bik, Wojciech ^a   Baranowska Bik, Agnieszka ^a   Wolinska Witort, Ewa ^a   Kalisz, Malgorzata ^a   Broczek, Katarzyna ^b   Mossakowska, Malgorzata ^c   Baranowska, Boguslawa ^a  

^a MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c INTERNATIONAL INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Poland)

Author keywords

Adiponectin; Centenarians; Health status; Longevity; Metabolic phenotype

Indexed keywords

ADIPONECTIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; ISOPROTEIN; LIPID; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HEALTH STATUS; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID METABOLISM; LONGEVITY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POLAND; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPONECTIN; ADIPOSE TISSUE; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; BODY MASS INDEX; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; FEMALE; GERIATRIC ASSESSMENT; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MOLECULAR WEIGHT; OBESITY; PROTEIN ISOFORMS; REGRESSION ANALYSIS; STATISTICS AS TOPIC; TRIGLYCERIDES;

EID: 84874755914     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2013.01.015     Document Type: Article

References (40)

1. Adamczak M., Rzepka E., Chudek J., Wiecek A. Ageing and plasma adiponectin concentration in apparently healthy males and females. Clin. Endocrinol. 2005, 62(1):114-118.
2. Arai Y., Nakazawa S., Kojima T., Takayama M., Abihara Y., Shimizu K., Yamamura K., Homma S., Osono Y., Gondo Y., Masui Y., Inagaki H., Kitagawa K., Hirose N. High adiponectin concentration and its role for longevity in female centenarians. Geriatr. Gerontol. Int. 2006, 6:32-39.
3. Arai Y., Takayama M., Abe Y., Hirose N. Adipokines and aging. J. Atheroscler. Thromb. 2011, 18(7):545-550.
4. Atzmon G., Pollin T.I., Crandall J., Tanner K., Schechter C.B., Scherer P.E., Rincon M., Siegel G., Katz M., Lipton R.B., Shuldiner A.R., Barzilai N. Adiponectin levels and genotype: a potential regulator of life span in humans. J. Gerontol. A Biol. Sci. Med. Sci. 2008, 63(5):447-453.
5. Baessler A., Schlossbauer S., Stark K., Strack C., Riegger G., Schunkert H., Hengstenberg C., Fischer M. Adiponectin multimeric forms but not total adiponectin levels are associated with myocardial infarction in non-diabetic men. J. Atheroscler. Thromb. 2011, 18(7):616-627.
6. Baldasseroni S., Antenore A., Di Serio C., Orso F., Lonetto G., Bartoli N., Foschini A., Marella A., Pratesi A., Scarantino S., Fumagalli S., Monami M., Mannucci E., Marchionni N., Tarantini F. Adiponectin, diabetes and ischemic heart failure: a challenging relationship. Cardiovasc. Diabetol. 2012, 11(1):151.
7. Barbieri M., Rizzo M.R., Manzella D., Paolisso G. Age-related insulin resistance: is it an obligatory finding? The lesson from healthy centenarians. Diabetes Metab. Res. Rev. 2001, 17(1):19-26.
8. Bik W., Baranowska-Bik A., Wolinska-Witort E., Martynska L., Chmielowska M., Szybinska A., Broczek K., Baranowska B. The relationship between adiponectin levels and metabolic status in centenarian, early elderly, young and obese women. Neuro Endocrinol. Lett. 2006, 27(4):493-500.
9. Denzel M.S., Scimia M.C., Zumstein P.M., Walsh K., Ruiz-Lozano P., Ranscht B. T-cadherin is critical for adiponectin-mediated cardioprotection in mice. J. Clin. Invest. 2010, 120(12):4342-4352.
10. Frystyk J., Berne C., Berglund L., Jensevik K., Flyvbjerg A., Zethelius B. Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men. J. Clin. Endocrinol. Metab. 2007, 92(2):571-576.
11. Gardener H., Sjoberg C., Crisby M., Goldberg R., Mendez A., Wright C.B., Elkind M.S., Sacco R.L., Rundek T. Adiponectin and carotid intima-media thickness in the northern Manhattan study. Stroke 2012, 43(4):1123-1125.
12. Goldstein B.J., Scalia R. Adiponectin: a novel adipokine linking adipocytes and vascular function. J. Clin. Endocrinol. Metab. 2004, 89(6):2563-2568.
13. Holland W.L., Miller R.A., Wang Z.V., Sun K., Barth B.M., Bui H.H., Davis K.E., Bikman B.T., Halberg N., Rutkowski J.M., Wade M.R., Tenorio V.M., Kuo M.S., Brozinick J.T., Zhang B.B., Birnbaum M.J., Summers S.A., Scherer P.E. Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat. Med. 2011, 17(1):55-63.
14. Hug C., Wang J., Ahmad N.S., Bogan J.S., Tsao T.S., Lodish H.F. T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. Proc. Natl. Acad. Sci. U. S. A. 2004, 101(28):10308-10313.
15. Hui X., Lam K.S., Vanhoutte P.M., Xu A. Adiponectin and cardiovascular health: an update. Br. J. Pharmacol. 2012, 165(3):574-590.
16. Kadowaki T., Yamauchi T., Kubota N. The physiological and pathophysiological role of adiponectin and adiponectin receptors in the peripheral tissues and CNS. FEBS Lett. 2008, 582(1):74-80.
17. Kanaya A.M., Wassel Fyr C., Vittinghoff E., Havel P.J., Cesari M., Nicklas B., Harris T., Newman A.B., Satterfield S., Cummings S.R. Health ABC Study. Serum adiponectin and coronary heart disease risk in older Black and White Americans. J. Clin. Endocrinol. Metab. 2006, 91(12):5044-5050.
18. Kizer J.R., Barzilay J.I., Kuller L.H., Gottdiener J.S. Adiponectin and risk of coronary heart disease in older men and women. J. Clin. Endocrinol. Metab. 2008, 93(9):3357-3364.
19. Kizer J.R., Arnold A.M., Strotmeyer E.S., Ives D.G., Cushman M., Ding J., Kritchevsky S.B., Chaves P.H., Hirsch C.H., Newman A.B. Change in circulating adiponectin in advanced old age: determinants and impact on physical function and mortality. The Cardiovascular Health Study All Stars Study. J. Gerontol. A Biol. Sci. Med. Sci. 2010, 65(11):1208-1214.
20. Kizer J.R., Arnold A.M., Jenny N.S., Cushman M., Strotmeyer E.S., Ives D.G., Ding J., Kritchevsky S.B., Chaves P.H., Hirsch C.H., Newman A.B. Longitudinal changes in adiponectin and inflammatory markers and relation to survival in the oldest old: the Cardiovascular Health Study All Stars study. J. Gerontol. A Biol. Sci. Med. Sci. 2011, 66(10):1100-1107.
21. Kizer J.R., Arnold A.M., Benkeser D., Ix J.H., Djousse L., Zieman S.J., Barzilay J.I., Tracy R.P., Mantzoros C.S., Siscovick D.S., Mukamal K.J. Total and high-molecular-weight adiponectin and risk of incident diabetes in older people. Diabetes Care 2012, 35(2):415-423.
22. Kobayashi H., Ouchi N., Kihara S., Walsh K., Kumada M., Abe Y., Funahashi T., Matsuzawa Y. Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ. Res. 2004, 94(4):e27-e31.
23. Laughlin G.A., Barrett-Connor E., May S., Langenberg C. Association of adiponectin with coronary heart disease and mortality: the Rancho Bernardo study. Am. J. Epidemiol. 2007, 165(2):164-174.
24. Magkos F., Sidossis L.S. Recent advances in the measurement of adiponectin isoform distribution. Curr. Opin. Clin. Nutr. Metab. Care 2007, 10(5):571-575.
25. Mao X., Kikani C.K., Riojas R.A., Langlais P., Wang L., Ramos F.J., Fang Q., Christ-Roberts C.Y., Hong J.Y., Kim R.Y., Liu F., Dong L.Q. APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function. Nat. Cell Biol. 2006, 8(5):516-523.
26. Matsuzawa Y. Adiponectin: a key player in obesity related disorders. Curr. Pharm. Des. 2010, 16(17):1896-1901.
27. Motta M., Bennati E., Ferlito L., Malaguarnera M., Motta L. Italian Multicenter Study on Centenarians (IMUSCE). Successful aging in centenarians: myths and reality. Arch. Gerontol. Geriatr. 2005, 40(3):241-251.
28. Paolisso G., Gambardella A., Ammendola S., D'Amore A., Balbi V., Varricchio M., D'Onofrio F. Glucose tolerance and insulin action in healthy centenarians. Am. J. Physiol. 1996, 270(5 Pt 1):E890-E894.
29. Park S.H., Carrero J.J., Lindholm B., Stenvinkel P. Adiponectin in chronic kidney disease has an opposite impact on protein-energy wasting and cardiovascular risk: two sides of the same coin. Clin. Nephrol. 2009, 72(2):87-96.
30. Poehls J., Wassel C.L., Harris T.B., Havel P.J., Swarbrick M.M., Cummings S.R., Newman A.B., Satterfield S., Kanaya A.M. Health ABC Study. Association of adiponectin with mortality in older adults: the Health, Aging, and Body Composition Study. Diabetologia 2009, 52(4):591-595.
31. Rizza S., Gigli F., Galli A., Micchelini B., Lauro D., Lauro R., Federici M. Adiponectin isoforms in elderly patients with or without coronary artery disease. J. Am. Geriatr. Soc. 2010, 58(4):702-706.
32. Sattar N., Watt P., Cherry L., Ebrahim S., Davey Smith G., Lawlor D.A. High molecular weight adiponectin is not associated with incident coronary heart disease in older women: a nested prospective case-control study. J. Clin. Endocrinol. Metab. 2008, 93(5):1846-1849.
33. Stenholm S., Koster A., Alley D.E., Visser M., Maggio M., Harris T.B., Egan J.M., Bandinelli S., Guralnik J.M., Ferrucci L. Adipocytokines and the metabolic syndrome among older persons with and without obesity: the InCHIANTI study. Clin. Endocrinol. 2010, 73(1):55-65.
34. Stenholm S., Metter E.J., Roth G.S., Ingram D.K., Mattison J.A., Taub D.D., Ferrucci L. Relationship between plasma ghrelin, insulin, leptin, interleukin 6, adiponectin, testosterone and longevity in the Baltimore Longitudinal Study of Aging. Aging Clin. Exp. Res. 2011, 23(2):153-158.
35. Szmitko P.E., Teoh H., Stewart D.J., Verma S. Adiponectin and cardiovascular disease: state of the art?. Am. J. Physiol. Heart Circ. Physiol. 2007, 292(4):H1655-H1663.
36. Takayama M., Hirose N., Arai Y., Gondo Y., Shimizu K., Ebihara Y., Yamamura K., Nakazawa S., Inagaki H., Masui Y., Kitagawa K. Morbidity of Tokyo-area centenarians and its relationship to functional status. J. Gerontol. A Biol. Sci. Med. Sci. 2007, 62(7):774-782.
37. Turer A.T., Scherer P.E. Adiponectin: mechanistic insights and clinical implications. Diabetologia 2012, 55(9):2319-2326.
38. Wannamethee S.G., Whincup P.H., Lennon L., Sattar N. Circulating adiponectin levels and mortality in elderly men with and without cardiovascular disease and heart failure. Arch. Intern. Med. 2007, 167(14):1510-1517.
39. Xu Y., Zhang C., Wang N., Ling F., Li P., Gao Y., Hua W. Adiponectin inhibits lymphotoxin-β receptor-mediated NF-κB signaling in human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun. 2011, 404(4):1060-1064.
40. Yamauchi T., Kamon J., Ito Y., Tsuchida A., Yokomizo T., Kita S., Sugiyama T., Miyagishi M., Hara K., Tsunoda M., Murakami K., Ohteki T., Uchida S., Takekawa S., Waki H., Tsuno N.H., Shibata Y., Terauchi Y., Froguel P., Tobe K., Koyasu S., Taira K., Kitamura T., Shimizu T., Nagai R., Kadowaki T. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003, 423(6941):762-769.